Literature DB >> 2032702

Serovar distribution of urogenital C trachomatis isolates in Germany.

H Näher1, D Petzoldt.   

Abstract

Using monoclonal antibodies in a microimmunofluorescence test the distribution of C trachomatis serovars isolated in the STD out-patient clinic of the Department of Dermatology of the University of Heidelberg was determined. Of 56 isolates investigated the most frequent was serovar E with 35.7%, followed by serovar D with 28.6% and serovar F with 26.8%. This shows that the distribution of C trachomatis in Germany is very similar to that in other Western countries.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2032702      PMCID： PMC1194643          DOI： 10.1136/sti.67.2.114

Source DB:  PubMed          Journal:  Genitourin Med        ISSN： 0266-4348


  13 in total

1.  CLASSIFICATION OF TRACHOMA VIRUS STRAINS BY PROTECTION OF MICE FROM TOXIC DEATH.

Authors:  S P WANG; J T GRAYSTON
Journal:  J Immunol       Date:  1963-06       Impact factor: 5.422

2.  Serovar determination of Chlamydia trachomatis isolates by using type-specific monoclonal antibodies.

Authors:  W J Newhall; P Terho; C E Wilde; B E Batteiger; R B Jones
Journal:  J Clin Microbiol       Date:  1986-02       Impact factor: 5.948

3.  Chlamydia trachomatis immunotypes in Finland.

Authors:  P Saikku; S P Wang
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1987-04

4.  Chlamydial infection. Results of micro-immunofluorescence tests for the detection of type-specific antibody in certain chlamydial infections.

Authors:  R S Dwyer; J D Treharne; B R Jones; J Herring
Journal:  Br J Vener Dis       Date:  1972-12

5.  Immunotypes of Chlamydia trachomatis isolates in Seattle, Washington.

Authors:  C C Kuo; S P Wang; K K Holmes; J T Grayston
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

6.  Further classification of TRIC agents from ocular trachoma and other sources by the mouse toxicity prevention test.

Authors:  E R Alexander; S P Wang; J T Grayston
Journal:  Am J Ophthalmol       Date:  1967-05       Impact factor: 5.258

7.  Immunotyping of Chlamydia trachomatis with monoclonal antibodies.

Authors:  S P Wang; C C Kuo; R C Barnes; R S Stephens; J T Grayston
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226

8.  Comparison of Chlamydia trachomatis serovars causing rectal and cervical infections.

Authors:  R C Barnes; A M Rompalo; W E Stamm
Journal:  J Infect Dis       Date:  1987-12       Impact factor: 5.226

9.  A simplified method for immunological typing of trachoma-inclusion conjunctivitis-lymphogranuloma venereum organisms.

Authors:  S P Wang; C C Kuo; J T Grayston
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

10.  Restriction endonuclease analysis of DNA from Chlamydia trachomatis biovars.

Authors:  E M Peterson; L M de la Maza
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948
View more
  4 in total

1.  Urogenital Chlamydia trachomatis serovars in men and women with a symptomatic or asymptomatic infection: an association with clinical manifestations?

Authors:  S A Morré; L Rozendaal; I G van Valkengoed; A J Boeke; P C van Voorst Vader; J Schirm; S de Blok; J A van Den Hoek; G J van Doornum; C J Meijer; A J van Den Brule
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Epidemiology of Chlamydia trachomatis using nested PCR.

Authors:  A Eley; M Khalili; M Abbott; R Patel; G R Kinghorn
Journal:  Genitourin Med       Date:  1993-06

3.  Chlamydia trachomatis serovar differentiation by direct sequence analysis of the variable segment 4 region of the major outer membrane protein gene.

Authors:  E Poole; I Lamont
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

4.  Evaluation of molecular typing for epidemiological study of Chlamydia trachomatis genital infections.

Authors:  P Rodriguez; B de Barbeyrac; K Persson; B Dutilh; C Bebear
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.